Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure of SEBI (Prohibition of Insider Trading) Regulations, 2015 - Citric India Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Ltd (BSE: 506365) has informed the stock exchange that it received a disclosure from its Promoter, Citric India Limited, under SEBI's Prohibition of Insider Trading Regulations. The promoter has reported sale of equity shares of the company in Form C, with transactions executed on 11 July 2025 and 12 July 2025. The disclosure was filed by Jay Desai, Director of Citric India Limited, on 14 July 2025. The exact number of shares sold and the resulting post-transaction promoter holding are partially obscured in the document but indicate multiple sale tranches on consecutive trading days.
This is a disclosure of share sales by a corporate promoter, which retail investors typically monitor as a signal of promoter sentiment. The actual percentage of promoter stake sold is not clearly visible in the filing, so shareholders should track further disclosures to assess any meaningful change in promoter holding.